Standout Papers

Molecular sequelae of proteasome inhibition in human multiple myeloma cells 2002 2026 2010 2018 592
  1. Molecular sequelae of proteasome inhibition in human multiple myeloma cells (2002)
    Nicholas Mitsiades, Constantine Mitsiades et al. Proceedings of the National Academy of Sciences
  2. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications (2003)
    Nicholas Mitsiades, Constantine S. Mitsiades et al. Blood

Immediate Impact

6 by Nobel laureates 21 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
ImmunoPET: Concept, Design, and Applications
2020 Standout
1 intermediate paper

Works of Marie Joseph being referenced

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
2004
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
2002 Standout

Author Peers

Author Last Decade Papers Cites
Marie Joseph 2309 55 887 991 16 3.3k
Unnur Þorsteinsdóttir 2788 7 387 735 66 5.8k
Timothy C. Burn 3439 91 779 618 90 5.7k
Anita L. Hawkins 1897 23 701 352 60 4.0k
Amy R. Nelson 2463 68 1074 211 33 7.8k
Jesper Frank Christensen 4787 39 1351 505 99 7.8k
Jin Yu 2961 18 238 153 15 5.7k
Charles B. Epstein 4625 15 612 302 53 6.1k
Hashem A. Shihab 2902 14 337 135 23 6.8k
Carla Costa 1565 6 832 113 27 2.7k
Susan D. Croll 2684 314 590 134 37 6.2k

All Works

Loading papers...

Rankless by CCL
2026